J Clin Neurol.  2017 Jul;13(3):234-242. 10.3988/jcn.2017.13.3.234.

Prognosis of Patients with Behavioral Variant Frontotemporal Dementia Who have Focal Versus Diffuse Frontal Atrophy

Affiliations
  • 1Department of Neurology, Kyung Hee University Hospital, Seoul, Korea.
  • 2Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, Korea.
  • 3Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dukna@skku.edu
  • 4Neuroscience Center, Samsung Medical Center, Seoul, Korea.
  • 5Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • 6Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
  • 7Department of Neurology, Chungnam National University Hospital, Daejeon, Korea.
  • 8Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea.
  • 9Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • 10Department of Neurology, Chonnam National University Medical School, Gwangju, Korea.
  • 11Department of Neurology, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea.
  • 12Department of Neurology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea.
  • 13Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.
  • 14Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 15Department of Neurology, College of Medicine, Hanyang University, Seoul, Korea.
  • 16Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • 17Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, Korea.

Abstract

BACKGROUND AND PURPOSE
Only a few studies have investigated the relationship between different subtypes and disease progression or prognosis in patients with behavioral variant frontotemporal dementia (bvFTD). Since a localized injury often produces more focal signs than a diffuse injury, we hypothesized that the clinical characteristics differ between patients with bvFTD who show diffuse frontal lobe atrophy (D-type) on axial magnetic resonance imaging (MRI) scans versus those with focal or circumscribed frontal lobe atrophy (F-type).
METHODS
In total, 94 MRI scans (74 scans from bvFTD and 20 scans from age-matched normal controls) were classified into 35 D- and 39 F-type bvFTD cases based on an axial MRI visual rating scale. We compared baseline clinical characteristics, progression in motor and cognitive symptoms, and survival times between D- and F-types. Survival analyses were performed for 62 of the 74 patients.
RESULTS
While D-type performed better on neuropsychological tests than F-type at baseline, D-type had higher baseline scores on the Unified Parkinson's Disease Rating Scale (UPDRS) Part III. Evaluations of motor progression showed that the disease duration with motor symptoms was shorter in D-type than F-type. Moreover, the survival time was shorter in D-type (6.9 years) than F-type (9.4 years). Cox regression analyses revealed that a high UPDRS Part III score at baseline contributed to an increased risk of mortality, regardless of the pattern of atrophy.
CONCLUSIONS
The prognosis is worse for D-type than for those with F-type. Shorter survival in D-type may be associated with the earlier appearance of motor symptoms.

Keyword

frontotemporal dementia; frontotemporal lobar degeneration; magnetic resonance imaging; prognosis

MeSH Terms

Atrophy*
Disease Progression
Frontal Lobe
Frontotemporal Dementia*
Frontotemporal Lobar Degeneration
Humans
Magnetic Resonance Imaging
Mortality
Neurobehavioral Manifestations
Neuropsychological Tests
Parkinson Disease
Prognosis*

Figure

  • Fig. 1 Standard images for the magnetic resonance imaging (MRI) visual rating. Standard no. 1 (A), standard no. 2 (B), and standard no. 3 (C). The images in each column represent the following levels: the slice just superior to the lateral ventricle on either side of the brain (left), the slice just superior to the last view of the insular cortex on either side of the brain (middle), and the slice with the most complete view of the orbitofrontal cortex around the interpeduncular cistern (right).

  • Fig. 2 Kaplan-Meier plots for groups defined by MRI visual rating subtypes. The end point is predefined as the occurrence of death (| or Δ: cases where death had not occurred by the final follow-up, p=0.048 in log-rank test). D-type: diffuse type, F-type: focal type.


Reference

1. Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011; 122:137–153. PMID: 21614463.
Article
2. Snowden JS, Bathgate D, Varma A, Blackshaw A, Gibbons ZC, Neary D. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry. 2001; 70:323–332. PMID: 11181853.
Article
3. Whitwell JL, Przybelski SA, Weigand SD, Ivnik RJ, Vemuri P, Gunter JL, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain. 2009; 132(Pt 11):2932–2946. PMID: 19762452.
Article
4. Kim EJ, Rabinovici GD, Seeley WW, Halabi C, Shu H, Weiner MW, et al. Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. 2007; 78:1375–1378. PMID: 17615169.
Article
5. Borroni B, Benussi A, Cosseddu M, Archetti S, Padovani A. Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. Neurodegener Dis. 2014; 13:224–229. PMID: 24029600.
Article
6. Borroni B, Grassi M, Archetti S, Papetti A, Del Bo R, Bonvicini C, et al. Genetic background predicts poor prognosis in frontotemporal lobar degeneration. Neurodegener Dis. 2011; 8:289–295. PMID: 21311163.
Article
7. Josephs KA, Whitwell JL, Weigand SD, Senjem ML, Boeve BF, Knopman DS, et al. Predicting functional decline in behavioural variant frontotemporal dementia. Brain. 2011; 134(Pt 2):432–448. PMID: 21252111.
Article
8. Ranasinghe KG, Rankin KP, Pressman PS, Perry DC, Lobach IV, Seeley WW, et al. Distinct subtypes of behavioral variant frontotemporal dementia based on patterns of network degeneration. JAMA Neurol. 2016; 73:1078–1088. PMID: 27429218.
Article
9. Bergeron C, Morris HR, Rossor M. Pick's disease. In : Dickson DW, editor. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel: ISN Neuropath Press;2003. p. 124–131.
10. Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006; 63:81–86. PMID: 16401739.
Article
11. Rankin KP, Mayo MC, Seeley WW, Lee S, Rabinovici G, Gorno-Tempini ML, et al. Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease. J Mol Neurosci. 2011; 45:594–608. PMID: 21881831.
Article
12. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol. 2006; 59:952–962. PMID: 16718704.
Article
13. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134(Pt 9):2456–2477. PMID: 21810890.
14. Kim EJ, Park KW, Lee JH, Choi S, Jeong JH, Yoon SJ, et al. Clinical and neuropsychological characteristics of a nationwide hospital-based registry of frontotemporal dementia patients in Korea: a CREDOS-FTD study. Dement Geriatr Cogn Dis Extra. 2014; 4:242–251. PMID: 25177333.
Article
15. Park HK, Na DL, Han SH, Kim JY, Cheong HK, Kim SY, et al. Clinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer's disease patients in Korea: a CREDOS (Clinical Research Center for Dementia of South Korea) study. J Korean Med Sci. 2011; 26:1219–1226. PMID: 21935279.
Article
16. Han C, Jo SA, Jo I, Kim E, Park MH, Kang Y. An adaptation of the Korean Mini-Mental State Examination (K-MMSE) in elderly Koreans: demographic influence and population-based norms (the AGE study). Arch Gerontol Geriatr. 2008; 47:302–310. PMID: 17936377.
Article
17. Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. 2008; 131(Pt 11):2957–2968. PMID: 18829698.
Article
18. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982; 139:1136–1139. PMID: 7114305.
19. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol. 1975; 32:632–637. PMID: 1164215.
Article
20. Lesher EL, Berryhill JS. Validation of the Geriatric Depression Scale-short form among inpatients. J Clin Psychol. 1994; 50:256–260. PMID: 8014251.
Article
21. Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, et al. Seoul Neuropsychological Screening Battery-Dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci. 2010; 25:1071–1076. PMID: 20592901.
Article
22. Sinoff G, Ore L. The Barthel Activities of Daily Living index: self-reporting versus actual performance in the old-old (> or = 75 years). J Am Geriatr Soc. 1997; 45:832–836. PMID: 9215334.
23. Ku HM, Kim JH, Kwon EJ, Kim SH, Lee HS, Ko HJ, et al. A study on the reliability and validity of Seoul-Instrumental Activities of Daily Living (S-IADL). J Korean Neuropsychiatr Assoc. 2004; 43:189–199.
24. Kang SJ, Choi SH, Lee BH, Jeong Y, Hahm DS, Han IW, et al. Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI). J Geriatr Psychiatry Neurol. 2004; 17:32–35. PMID: 15018695.
Article
25. Kertesz A, Nadkarni N, Davidson W, Thomas AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000; 6:460–468. PMID: 10902415.
Article
26. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008; 23:2129–2170. PMID: 19025984.
Article
27. Chow TW, Gao F, Links KA, Ween JE, Tang-Wai DF, Ramirez J, et al. Visual rating versus volumetry to detect frontotemporal dementia. Dement Geriatr Cogn Disord. 2011; 31:371–378. PMID: 21625137.
Article
28. Victoroff J, Mack WJ, Grafton ST, Schreiber SS, Chui HC. A method to improve interrater reliability of visual inspection of brain MRI scans in dementia. Neurology. 1994; 44:2267–2276. PMID: 7991111.
Article
29. Scheltens P, Pasquier F, Weerts JG, Barkhof F, Leys D. Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol. 1997; 37:95–99. PMID: 9058064.
Article
30. Pan XD, Chen XC. Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review. Transl Neurodegener. 2013; 2:8. PMID: 23597030.
Article
31. Garcin B, Lillo P, Hornberger M, Piguet O, Dawson K, Nestor PJ, et al. Determinants of survival in behavioral variant frontotemporal dementia. Neurology. 2009; 73:1656–1661. PMID: 19917988.
Article
32. Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR. Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia. Neurology. 2009; 72:732–737. PMID: 19237702.
Article
33. Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, et al. Distinct genetic forms of frontotemporal dementia. Neurology. 2008; 71:1220–1226. PMID: 18703462.
Article
34. Padovani A, Agosti C, Premi E, Bellelli G, Borroni B. Extrapyramidal symptoms in frontotemporal dementia: prevalence and clinical correlations. Neurosci Lett. 2007; 422:39–42. PMID: 17574750.
Article
35. Lagarde J, Valabrègue R, Corvol JC, Pineau F, Le Ber I, Vidailhet M, et al. Are frontal cognitive and atrophy patterns different in PSP and bvFTD? A comparative neuropsychological and VBM study. PLoS One. 2013; 8:e80353. PMID: 24278277.
Article
36. Kitagaki H, Hirono N, Ishii K, Mori E. Corticobasal degeneration: evaluation of cortical atrophy by means of hemispheric surface display generated with MR images. Radiology. 2000; 216:31–38. PMID: 10887225.
Article
37. Whitwell JL, Jack CR, Parisi JE, Knopman DS, Boeve BF, Petersen RC, et al. Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia. J Mol Neurosci. 2011; 45:372–378. PMID: 21556732.
Article
38. Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005; 65:719–725. PMID: 16157905.
Article
39. Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003; 61:349–354. PMID: 12913196.
Article
40. Kang SJ, Cha KR, Seo SW, Kim EA, Cheong HK, Kim EJ, et al. Survival in frontotemporal lobar degeneration in a Korean population. Alzheimer Dis Assoc Disord. 2010; 24:339–342. PMID: 20625272.
Article
41. Kansal K, Mareddy M, Sloane KL, Minc AA, Rabins PV, McGready JB, et al. Survival in frontotemporal dementia phenotypes: a meta-analysis. Dement Geriatr Cogn Disord. 2016; 41:109–122. PMID: 26854827.
Article
42. Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015; 72:438–445. PMID: 25786075.
43. Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, Senjem ML, et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology. 2009; 73:1443–1450. PMID: 19884571.
Article
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr